Literature DB >> 17596751

Clinicopathological parameters and expression of P-glycoprotein and MRP-1 in retinoblastoma.

Günhal Kamburoğlu1, Hayyam Kiratli, Figen Söylemezoğlu, Sevgül Bilgiç.   

Abstract

PURPOSE: The immunohistochemical expressions of two multidrug resistance proteins, P-glycoprotein (P-gp) and multidrug resistance-related protein-1 (MRP-1), were studied in retinoblastoma and the correlations with the clinicopathological parameters were assessed.
METHOD: Sixty-five enucleated eyes containing retinoblastoma were included in the study. Following hematoxylin-eosin staining, tumor differentiation, presence of choroidal invasion, optic nerve invasion, retinal invasion, necrosis and presence of calcification were evaluated with the light microscope. P-gp and MRP-1 expressions were evaluated immunohistochemically.
RESULTS: Fifty-three eyes were enucleated primarily and 12 eyes were operated after failure of chemotherapy. P-gp and MRP-1 expressions were positive in 69.3 and 73.4% of specimens, respectively. There was no statistically significant relationship between the expressions of P-gp and MRP-1, and tumor differentiation, presence of tumor invasion or treatment with chemotherapy.
CONCLUSION: Retinoblastoma intrinsically expresses both P-gp and MRP-1 and their expressions are not related to tumor differentiation. The expressions of P-gp and MRP-1 do not seem to be induced by chemotherapy and are not related to the degree of tumor invasion. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17596751     DOI: 10.1159/000104680

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  7 in total

1.  Expression of multidrug resistance proteins in retinoblastoma.

Authors:  Swati Shukla; Arpna Srivastava; Sunil Kumar; Usha Singh; Sandeep Goswami; Bhavna Chawla; Mandeep Singh Bajaj; Seema Kashyap; Jasbir Kaur
Journal:  Int J Ophthalmol       Date:  2017-11-18       Impact factor: 1.779

Review 2.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

Review 3.  Molecular biology of retinoblastoma.

Authors:  C Sábado Alvarez
Journal:  Clin Transl Oncol       Date:  2008-07       Impact factor: 3.405

4.  Characterization of the ATP-binding cassette transporter gene expression profile in Y79: a retinoblastoma cell line.

Authors:  Doris Hendig; Thomas Langmann; Ralf Zarbock; Gerd Schmitz; Knut Kleesiek; Christian Götting
Journal:  Mol Cell Biochem       Date:  2009-03-06       Impact factor: 3.396

5.  Expression of multidrug-resistance associated proteins in human retinoblastoma treated by primary enucleation.

Authors:  Li-Juan Tang; Li-Jun Zhou; Wen-Xin Zhang; Jian-Yan Lin; Yong-Ping Li; Hua-Sheng Yang; Ping Zhang
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

6.  Glioblastoma entities express subtle differences in molecular composition and response to treatment.

Authors:  Joana Balça-Silva; Diana Matias; Anália Do Carmo; Luiz Gustavo Dubois; Ana Cristina Gonçalves; Henrique Girão; Nathalie Henriques Silva Canedo; Ana Helena Correia; Jorge Marcondes De Souza; Ana Bela Sarmento-Ribeiro; Maria Celeste Lopes; Vivaldo Moura-Neto
Journal:  Oncol Rep       Date:  2017-07-07       Impact factor: 3.906

7.  Correlation of Technical and Adjunctive Factors with Quantitative Tumor Reduction in Children Undergoing Selective Ophthalmic Artery Infusion Chemotherapy for Retinoblastoma.

Authors:  T Abruzzo; K Abraham; K B Karani; J I Geller; S Vadivelu; J M Racadio; B Zhang; Z M Correa
Journal:  AJNR Am J Neuroradiol       Date:  2020-12-24       Impact factor: 3.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.